Congress cuts off NIH funding for animal research abroad

What it does

This bill prohibits the National Institutes of Health from funding animal research conducted outside the United States. It bars NIH grants, contracts, and cooperative agreements for any live-animal research project unless the work happens on U.S. soil or in U.S. territories. The stated rationale is that foreign research organizations receiving U.S. taxpayer money lack adequate oversight and self-report animal welfare, creating risk of mistreatment.

Why we flagged it

The bill's operative mechanism is a geographic restriction on NIH funding for live-animal research, grounded in animal-welfare and taxpayer-accountability concerns. It is not a deregulation, subsidy, or commemorative measure—it is a conditional funding prohibition.

What the text implies

• May incentivize relocation of NIH-funded animal research to U.S. facilities, increasing domestic research infrastructure costs and potentially raising the cost of NIH-funded studies.
• Could reduce U.S. researchers' ability to conduct comparative or population-specific studies in non-U.S. settings where certain animal models or disease prevalence are more readily available.
• Assumes U.S. animal-welfare oversight is superior to foreign oversight; does not establish a mechanism to verify compliance with the new rule or audit existing foreign grants during transition.
• May affect international research collaborations and partnerships, potentially reducing U.S. scientific competitiveness in fields where overseas research infrastructure is specialized or cost-effective.
• The bill does not address what happens to ongoing grants or contracts already awarded to foreign organizations—transition rules and enforcement mechanisms are not specified in the text.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Citizens benefit from reduced taxpayer funding of potentially poorly-overseen foreign animal research and alignment of U.S. funding with domestic animal-welfare standards. However, the bill may reduce access to certain research models, increase costs for NIH-funded studies, and potentially slow scientific progress if critical research cannot be conducted domestically—effects that could delay medical advances benefiting patients.

Who stands to gain

• U.S.-based research institutions and universities
• Domestic contract research organizations (CROs) conducting animal research
• U.S. animal-care and facility-management service providers

Named in the bill

National Institutes of Health (NIH), Public Health Service Act, Section 495, Foreign research organizations, U.S. States, territories, and possessions

Where it stands

3 cosponsors: 2 Republicans, 1 Democrats.

• May 19, 2025 — Introduced · Congress.gov: “Introduced in Senate”
• May 19, 2025 — Referred to Senate Committee on Health, Education, Labor, and Pensions · Congress.gov: “Read twice and referred to the Committee on Health, Education, Labor, and Pensions”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

1 lobbying clients named this bill on 2 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $114,556 in lobbying spend. A filing names 9 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 0% of bills with at least one filing.

Rick Scott, the sponsor, reported $69,750 in PAC receipts in the 2026 cycle.

• Physicians Committee for Responsible Medicine — $114,556 on 2 filings

Lobbying Disclosure Act filings through Jul 16, 2026. A filing shows who paid to lobby on a bill it names, not what changed.